Who owns REGULUS THERAPEUTICS INC?
- Ticker: RGLS
- CUSIP Number: 75915k309
Tip: Access positions for across all investors
Analyze quarterly positions in Regulus Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Regulus Therapeutics stock
Who bought or sold REGULUS THERAPEUTICS INC this quarter?
Fund or Company Name |
Shares Held |
Valued At |
Change in Shares |
As Of |
Actions |
|---|---|---|---|---|---|
| Federated Investors | 13M | $20M | 0% | Dec 2024 |
|
| NEA Management Company | 6.5M | $10M | 0% | Dec 2024 |
|
| Vivo Capital | 5.0M | $7.9M | 0% | Dec 2024 |
|
| Octagon Capital Advisors | 4.8M | $7.7M | 14% | Dec 2024 |
|
| BlackRock | 4.2M | $6.7M | 4% | Dec 2024 |
|
| Vanguard Group | 4.0M | $6.3M | -3% | Dec 2024 |
|
| Deep Track Capital | 3.3M | $5.2M | 0% | Dec 2024 |
|
| Millennium Management | 2.2M | $3.5M | 70% | Dec 2024 |
|
| Adage Capital Partners GP | 2.0M | $3.2M | 0% | Dec 2024 |
|
| Geode Capital Management | 1.3M | $2.0M | 0% | Dec 2024 |
|
| State Street Corporation | 1.1M | $1.7M | 6% | Dec 2024 |
|
| Alyeska Investment Group | 1.0M | $1.6M | 0% | Dec 2024 |
|
| Point72 Asset Management | 895k | $1.4M | 0% | Dec 2024 |
|
| DAFNA Capital Management | 875k | $1.4M | -2% | Dec 2024 |
|
| Northern Trust | 457k | $722k | -8% | Dec 2024 |
|
| Victory Capital Management | 390k | $616k | -2% | Dec 2024 |
|
| RA Capital Management | 337k | $532k | -56% | Dec 2024 |
|
| Goldman Sachs Group | 212k | $336k | 19% | Dec 2024 |
|
| Jpmorgan Chase & Co | 191k | $301k | 141% | Dec 2024 |
|
| Charles Schwab Investment Management | 179k | $283k | 0% | Dec 2024 |
|
| Citadel Advisors | 163k | $257k | 322% | Dec 2024 |
|
| Bank of New York Mellon | 149k | $236k | 0% | Dec 2024 |
|
| Morgan Stanley | 140k | $221k | -17% | Dec 2024 |
|
| Renaissance Technologies | 117k | $185k | 20% | Dec 2024 |
|
| Tyche Wealth Partners | 106k | $168k | 0% | Dec 2024 |
|
| Barclays | 96k | $152k | 14% | Dec 2024 |
|
| UBS Group | 90k | $142k | 202% | Dec 2024 |
|
| Nuveen Asset Management | 86k | $135k | 0% | Dec 2024 |
|
| Velan Capital Investment Management | 70k | $111k | 100% | Dec 2024 |
|
| Peak6 | 60k | $95k | 100% | Dec 2024 |
|
| Rhumbline Advisers | 58k | $101k | -3% | Mar 2025 |
|
| Bank of America Corporation | 54k | $85k | -1% | Dec 2024 |
|
| Citigroup | 50k | $79k | -7% | Dec 2024 |
|
| LPL Financial | 50k | $79k | -14% | Dec 2024 |
|
| Susquehanna International | 50k | $79k | 5% | Dec 2024 |
|
| New York State Common Retirement Fund | 49k | $78k | 0% | Dec 2024 |
|
| Mirae Asset Global Etfs Holdings | 37k | $58k | 4% | Dec 2024 |
|
| Wells Fargo & Company | 35k | $53k | 32% | Dec 2024 |
|
| Corebridge Financial | 31k | $50k | 100% | Dec 2024 |
|
| Invesco | 30k | $48k | 7% | Dec 2024 |
|
| T. Rowe Price Associates | 30k | $47k | -99% | Dec 2024 |
|
| Intech Investment Management | 29k | $45k | 100% | Dec 2024 |
|
| Alliancebernstein | 27k | $43k | 0% | Dec 2024 |
|
| Ing Investment Management | 23k | $37k | 0% | Dec 2024 |
|
| Two Sigma Investments | 22k | $35k | 16% | Dec 2024 |
|
| SG Americas Securities | 19k | $33k | -29% | Mar 2025 |
|
| ProShare Advisors | 18k | $28k | 49% | Dec 2024 |
|
| Creative Planning | 14k | $22k | -14% | Dec 2024 |
|
| Commonwealth Equity Services | 12k | $18k | 2% | Dec 2024 |
|
| Tower Research Capital | 11k | $18k | 62% | Dec 2024 |
|
| Royal Bank of Canada | 7.8k | $11k | 25% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 7.2k | $11k | 100% | Dec 2024 |
|
| Summit Investment Advisors | 6.2k | $9.8k | 0% | Dec 2024 |
|
| Legal & General Group | 6.0k | $9.4k | 0% | Dec 2024 |
|
| FMR | 5.6k | $8.8k | -98% | Dec 2024 |
|
| California State Teachers Retirement System | 4.6k | $7.2k | 0% | Dec 2024 |
|
| Amalgamated Bank | 2.2k | $3.0k | 0% | Dec 2024 |
|
| Sterling Capital Management | 1.6k | $2.6k | 875% | Dec 2024 |
|
| Advisor Group Holdings | 800.00 | $1.3k | 0% | Dec 2024 |
|
| NISA Investment Advisors | 760.00 | $1.2k | 100% | Dec 2024 |
|
| Community Bank | 690.00 | $1.1k | 0% | Dec 2024 |
|
| CWM | 496.00 | $999.985600 | 28% | Dec 2024 |
|
| Russell Investments | 458.00 | $724.006400 | 100% | Dec 2024 |
|
| SBI Securities | 412.00 | $651.001200 | 100% | Dec 2024 |
|
| Continuum Advisory | 300.00 | $474.000000 | 0% | Dec 2024 |
|
| Lazard Asset Management | 122.00 | $0 | 0% | Dec 2024 |
|
| EverSource Wealth Advisors | 82.00 | $130.002800 | 100% | Dec 2024 |
|
Who sold out of Regulus Therapeutics?
Fund or Company Name |
Date Sold |
Shares Held |
Valued At |
|---|---|---|---|
| Woodline Partners | Sep 2024 | 949k | $1.5M |
| Opaleye Management | Sep 2024 | 535k | $840k |
| TD Asset Management | Sep 2024 | 302k | $486k |
| Sarissa Capital Management | Sep 2024 | 185k | $291k |
| Monashee Investment Management | Sep 2024 | 147k | $231k |
| Manufacturers Life Insurance Company | Sep 2024 | 130k | $204k |
| American Century Companies | Sep 2024 | 39k | $61k |
| AQR Capital Management | Sep 2024 | 30k | $47k |
| Jane Street | Sep 2024 | 30k | $46k |
| Hsbc Holdings | Sep 2024 | 19k | $30k |
| Wolverine Trading | Sep 2024 | 14k | $22k |